dc.contributor.author | Mumusoglu, Sezcan | |
dc.contributor.author | Turan, Volkan | |
dc.contributor.author | Uckan, Hasan | |
dc.contributor.author | Suzer, Aysegul | |
dc.contributor.author | Sokmensuer, Lale Karakoc | |
dc.contributor.author | Bozdag, Gurkan | |
dc.date.accessioned | 2021-12-21T08:45:55Z | |
dc.date.available | 2021-12-21T08:45:55Z | |
dc.date.issued | 2018 | |
dc.identifier.issn | 1933-7191 | |
dc.identifier.issn | 1933-7205 | |
dc.identifier.uri | https://doi.org/10.1177/1933719117741376 | |
dc.identifier.uri | http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/1825 | |
dc.description.abstract | In animal studies, intravenous continuous infusion or peritoneal injection of sphingosine-1-phosphate (S1P) has been shown to decrease chemotherapy- and radiotherapy-induced apoptosis on primordial follicles. Although a long-acting oral form of an S1P ana | |
dc.description.sponsorship | Hacettepe University Foundation of Scientific ResearchHacettepe University [THD-2015-6931]; Novartis Company (Basel, Switzerland) | |
dc.language.iso | English | |
dc.publisher | Sage Publıcatıons Inc | |
dc.title | The Impact of a Long-Acting Oral Sphingosine-1-Phosphate Analogue on Ovarian Aging in a Rat Model | |
dc.type | Article | |
dc.relation.journal | Reproductıve Scıences | |
dc.identifier.issue | 9 | |
dc.identifier.startpage | 1330 | |
dc.identifier.endpage | 1335 | |
dc.identifier.volume | 25 | |
dc.identifier.doi | 10.1177/1933719117741376 | |
dc.relation.issue | 9 | |
dc.relation.volume | 25 | |